- Home
- CRNX vs TXNM Comparison
CRNX vs TXNM Comparison
Compare CRNX & TXNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- TXNM
- Stock Information
- Founded
- CRNX 2008
- TXNM 1917
- Country
- CRNX United States
- TXNM United States
- Employees
- CRNX N/A
- TXNM N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- TXNM
- Sector
- CRNX Health Care
- TXNM
- Exchange
- CRNX Nasdaq
- TXNM NYSE
- Market Cap
- CRNX 2.8B
- TXNM 5.2B
- IPO Year
- CRNX 2018
- TXNM N/A
- Fundamental
- Price
- CRNX $31.75
- TXNM $56.31
- Analyst Decision
- CRNX Strong Buy
- TXNM Buy
- Analyst Count
- CRNX 8
- TXNM 7
- Target Price
- CRNX $74.86
- TXNM $54.86
- AVG Volume (30 Days)
- CRNX 725.8K
- TXNM 1.3M
- Earning Date
- CRNX 08-07-2025
- TXNM 07-30-2025
- Dividend Yield
- CRNX N/A
- TXNM 2.90%
- EPS Growth
- CRNX N/A
- TXNM 144.40
- EPS
- CRNX N/A
- TXNM 2.24
- Revenue
- CRNX $760,000.00
- TXNM $2,017,114,000.00
- Revenue This Year
- CRNX $402.02
- TXNM $10.59
- Revenue Next Year
- CRNX $771.03
- TXNM $5.09
- P/E Ratio
- CRNX N/A
- TXNM $25.16
- Revenue Growth
- CRNX N/A
- TXNM 10.11
- 52 Week Low
- CRNX $24.10
- TXNM $37.46
- 52 Week High
- CRNX $62.53
- TXNM $57.29
- Technical
- Relative Strength Index (RSI)
- CRNX 57.94
- TXNM 53.39
- Support Level
- CRNX $28.98
- TXNM $56.21
- Resistance Level
- CRNX $32.49
- TXNM $56.41
- Average True Range (ATR)
- CRNX 1.24
- TXNM 0.25
- MACD
- CRNX 0.30
- TXNM -0.09
- Stochastic Oscillator
- CRNX 90.54
- TXNM 22.95
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About TXNM TXNM ENERGY INC
TXNM Energy Inc is a holding company that owns regulated utility companies providing energy to houses and businesses across Texas and New Mexico using its utilities.